At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 7:21:38 PM EST
Major Holders
Breakdown | |
---|---|
13.46% | % of Shares Held by All Insider |
96.97% | % of Shares Held by Institutions |
112.05% | % of Float Held by Institutions |
246 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
EcoR1 Capital, LLC | 11.58M | Sep 30, 2024 | 21.53% | 148,162,940 |
FMR, LLC | 8.07M | Sep 30, 2024 | 14.99% | 103,176,712 |
Wellington Management Group, LLP | 4.18M | Sep 30, 2024 | 7.77% | 53,446,698 |
Blackrock Inc. | 4.03M | Sep 30, 2024 | 7.49% | 51,523,069 |
Price (T.Rowe) Associates Inc | 3.82M | Sep 30, 2024 | 7.10% | 48,888,930 |
Palo Alto Investors Lp | 1.74M | Sep 30, 2024 | 3.23% | 22,228,559 |
State Street Corporation | 1.67M | Sep 30, 2024 | 3.11% | 21,422,086 |
Armistice Capital, LLC | 1.65M | Sep 30, 2024 | 3.07% | 21,103,499 |
Vanguard Group Inc | 1.26M | Sep 30, 2024 | 2.34% | 16,103,901 |
Siren, L.L.C. | 1.1M | Sep 30, 2024 | 2.04% | 14,066,953 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Vanguard Specialized-Health Care Fund | 3.01M | Jul 31, 2024 | 5.59% | 38,467,242 |
Fidelity Growth Company Fund | 2.36M | Oct 31, 2024 | 4.38% | 30,123,992 |
Price (T.Rowe) New Horizons Fund | 1.89M | Sep 30, 2024 | 3.52% | 24,193,909 |
iShares Russell 2000 ETF | 1.1M | Sep 30, 2024 | 2.04% | 14,042,818 |
Fidelity Growth Company K6 Fund | 816.39k | Oct 31, 2024 | 1.52% | 10,441,628 |
Fidelity Series Growth Company Fund | 758.61k | Oct 31, 2024 | 1.41% | 9,702,557 |
Fidelity Select Portfolios - Biotechnology | 738.12k | Oct 31, 2024 | 1.37% | 9,440,516 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 715.34k | Sep 30, 2024 | 1.33% | 9,149,172 |
Vanguard Extended Market Index Fund | 551.67k | Sep 30, 2024 | 1.03% | 7,055,884 |
Price (T.Rowe) Health Sciences Fund | 525.01k | Sep 30, 2024 | 0.98% | 6,714,839 |
Related Tickers
NMRA Neumora Therapeutics, Inc.
10.32
-2.46%
PTGX Protagonist Therapeutics, Inc.
41.08
+1.73%
ANAB AnaptysBio, Inc.
15.59
+3.79%
CYTK Cytokinetics, Incorporated
48.65
-3.16%
MRUS Merus N.V.
42.83
+3.33%
SLRN Acelyrin, Inc.
3.2300
-8.76%
VRDN Viridian Therapeutics, Inc.
17.85
-0.78%
OKUR OnKure Therapeutics, Inc.
9.86
-8.96%
VYGR Voyager Therapeutics, Inc.
6.27
+0.32%
LXEO Lexeo Therapeutics, Inc.
6.88
-3.51%